212 related articles for article (PubMed ID: 892704)
1. Effect of a spirolactone on plasma and urinary aldosterone in primary aldosteronism.
Vetter H; Appenheimer M; Lucas R; Weiand H; Herschbach ML; Glänzer K; Witassek F; Krück F
Horm Res; 1977; 8(1):23-8. PubMed ID: 892704
[TBL] [Abstract][Full Text] [Related]
2. Primary aldosteronism with normal aldosterone levels in blood and urine.
Nomura K; Han DC; Jibiki K; Demura H; Tsushima T; Shizume K
Acta Endocrinol (Copenh); 1985 Dec; 110(4):522-5. PubMed ID: 4090913
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a test using saralasin to differentiate primary aldosteronism due to an aldosterone-producing adenoma from idiopathic hyperaldosteronism.
Brown RD; Kem DC; Hogan MJ; Hegstad RL
Metabolism; 1984 Aug; 33(8):734-8. PubMed ID: 6748946
[TBL] [Abstract][Full Text] [Related]
4. Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone.
Vetter H; Siebenschein R; Studer A; Witassek F; Furrer J; Glänzer K; Siegenthaler W; Vetter W
Acta Endocrinol (Copenh); 1978 Dec; 89(4):710-25. PubMed ID: 213920
[TBL] [Abstract][Full Text] [Related]
5. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism.
Magill SB; Raff H; Shaker JL; Brickner RC; Knechtges TE; Kehoe ME; Findling JW
J Clin Endocrinol Metab; 2001 Mar; 86(3):1066-71. PubMed ID: 11238487
[TBL] [Abstract][Full Text] [Related]
6. The effect of adrenal surgery on plasma atrial natriuretic factor and sodium escape phenomenon in patients with primary aldosteronism.
Nakada T; Furuta H; Katayama T; Sumiya H; Shimazaki J
J Urol; 1989 Jul; 142(1):13-8. PubMed ID: 2525199
[TBL] [Abstract][Full Text] [Related]
7. Primary aldosteronism. A study in contrasts.
Nicholls MG; Espiner EA; Hughes H; Ross J; Stewart DT
Am J Med; 1975 Sep; 59(3):334-42. PubMed ID: 169691
[TBL] [Abstract][Full Text] [Related]
8. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia.
Nakada T
Urol Int; 1984; 39(1):40-5. PubMed ID: 6375065
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone-producing-adenoma (A-P-A): effect of pregnancy.
Gordon RD; Tunny TJ
Clin Exp Hypertens A; 1982; 4(9-10):1685-93. PubMed ID: 6754149
[TBL] [Abstract][Full Text] [Related]
10. The absence of long-term therapeutic effect of calcium channel blockade in the primary aldosteronism of adrenal adenomas.
Bursztyn M; Grossman E; Rosenthal T
Am J Hypertens; 1988 Jul; 1(3 Pt 3):88S-90S. PubMed ID: 3046636
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone metabolites and possible aldosterone precursors in hypertension.
Vecsei P; Abdelhamid S; Mittelstädt GV; Lichtwald K; Haack D; Lewicka S
J Steroid Biochem; 1983 Jul; 19(1A):345-51. PubMed ID: 6887870
[TBL] [Abstract][Full Text] [Related]
12. The changing clinical spectrum of primary aldosteronism.
Bravo EL; Tarazi RC; Dustan HP; Fouad FM; Textor SC; Gifford RW; Vidt DG
Am J Med; 1983 Apr; 74(4):641-51. PubMed ID: 6340491
[TBL] [Abstract][Full Text] [Related]
13. Detection of primary aldosteronism by the 6-hour integrated aldosterone/renin ratio.
Zadik Z; Levin PA; Hamilton BP; Kowarski AA
Hypertension; 1986 Apr; 8(4):285-9. PubMed ID: 3514448
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
[TBL] [Abstract][Full Text] [Related]
15. [Current problems in primary aldosteronism--4 cases of normokalemic primary aldosteronism (1st degree) caused by adenoma and 3 cases of aldosteronism, 1st degree, caused by hyperplasia (2 hypokalemic cases, a normokalemic case)].
Oda T
Naika; 1969 Oct; 24(4):713-24. PubMed ID: 5358678
[No Abstract] [Full Text] [Related]
16. Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism.
Kater CE; Biglieri EG; Schambelan M; Arteaga E
Hypertension; 1983; 5(6 Pt 3):V115-21. PubMed ID: 6360878
[TBL] [Abstract][Full Text] [Related]
17. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.
Kem DC; Weinberger MH; Gomez-Sanchez C; Kramer NJ; Lerman R; Furuyama S; Nugent CA
J Clin Invest; 1973 Sep; 52(9):2272-7. PubMed ID: 4353776
[TBL] [Abstract][Full Text] [Related]
18. Adrenal adenoma with primary aldosteronism in a child: a case report.
Lai FC; Chen HC; Peng HC; Chang WT; Wen MC
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Oct; 54(4):274-8. PubMed ID: 7982140
[TBL] [Abstract][Full Text] [Related]
19. Effect of aldosterone antagonist canrenone on plasma aldosterone concentration and plasma renin activity, and on the excretion of aldosterone and electrolytes by man.
Erbler HC; Wernze H; Hilfenhaus M
Eur J Clin Pharmacol; 1976 Feb; 9(4):253-7. PubMed ID: 971711
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic regulation of aldosterone secretion: its pathophysiologic significance in subsets of primary aldosteronism.
Naruse M; Naruse K; Yoshimoto T; Tanaka M; Tanabe A; Imaki T; Shibasaki T; Demura R; Demura H
Hypertens Res; 1995 Jun; 18 Suppl 1():S59-64. PubMed ID: 8529076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
